BNP Paribas Financial Markets’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.2M Sell
699,795
-27,991
-4% -$542K 0.01% 1326
2025
Q4
$15.7M Sell
727,786
-1,053,562
-59% -$22.2M 0.01% 1337
2025
Q3
$34.3M Buy
1,781,348
+547,599
+44% +$9.76M 0.03% 800
2025
Q2
$21.1M Buy
1,233,749
+1,199,741
+3,528% +$51.2M 0.02% 1017
2025
Q1
$2.17M Buy
34,008
+6,560
+24% +$691K ﹤0.01% 2317
2024
Q4
$3.34M Buy
27,448
+117
+0.4% +$14.3K ﹤0.01% 2049
2024
Q3
$3.41M Sell
27,331
-47,495
-63% -$6.57M ﹤0.01% 1724
2024
Q2
$11.8M Sell
74,826
-150,556
-67% -$19.3M 0.01% 1007
2024
Q1
$29.2M Buy
225,382
+76,956
+52% +$9.43M 0.04% 607
2023
Q4
$14.3M Buy
148,426
+118,196
+391% +$11.3M 0.03% 858
2023
Q3
$3.66M Buy
30,230
+9,805
+48% +$1.11M 0.01% 1481
2023
Q2
$2.34M Sell
20,425
-138,576
-87% -$17.9M ﹤0.01% 1660
2023
Q1
$21.9M Buy
159,001
+121,424
+323% +$15.8M 0.05% 550
2022
Q4
$4.87M Buy
+37,577
New +$4.35M 0.01% 1325
2022
Q3
Sell
-69,724
Closed -$5.23M 5019
2022
Q2
$5.23M Sell
69,724
-61,229
-47% -$4.5M 0.01% 1217
2022
Q1
$10.2M Sell
130,953
-12,656
-9% -$969K 0.02% 921
2021
Q4
$12.9M Buy
143,609
+82,625
+135% +$7.06M 0.03% 842
2021
Q3
$5.64M Buy
60,984
+24,233
+66% +$1.87M 0.01% 1236
2021
Q2
$2.86M Sell
36,751
-6,698
-15% -$508K 0.01% 1578
2021
Q1
$3.24M Buy
43,449
+16,939
+64% +$1.56M 0.01% 1413
2020
Q4
$4.52M Buy
26,510
+2,509
+10% +$372K 0.02% 1198
2020
Q3
$3.37M Sell
24,001
-9,354
-28% -$1.42M 0.01% 1274
2020
Q2
$5.35M Sell
33,355
-5,320
-14% -$724K 0.01% 1019
2020
Q1
$3.78M Buy
38,675
+10,862
+39% +$1.24M 0.01% 1119
2019
Q4
$3.59M Buy
27,813
+3,750
+16% +$378K 0.01% 1376
2019
Q3
$1.81M Buy
24,063
+16,574
+221% +$1.96M 0.01% 1563
2019
Q2
$1.14M Buy
7,489
+4,813
+180% +$585K ﹤0.01% 1694
2019
Q1
$319K Buy
2,676
+98
+4% +$12.6K ﹤0.01% 2399
2018
Q4
$281K Sell
2,578
-4,845
-65% -$606K ﹤0.01% 1990
2018
Q3
$1.2M Buy
7,423
+5,203
+234% +$711K ﹤0.01% 1693
2018
Q2
$293K Sell
2,220
-15,362
-87% -$1.45M ﹤0.01% 2255
2018
Q1
$1.3M Buy
17,582
+1,907
+12% +$127K ﹤0.01% 1572
2017
Q4
$872K Buy
15,675
+8,883
+131% +$471K ﹤0.01% 2084
2017
Q3
$308K Buy
6,792
+303
+5% +$12.1K ﹤0.01% 2239
2017
Q2
$219K Buy
6,489
+5,306
+449% +$173K ﹤0.01% 2395
2017
Q1
$35K Sell
1,183
-721
-38% -$22.3K ﹤0.01% 2863
2016
Q4
$52.2K Sell
1,904
-1,637
-46% -$65.7K ﹤0.01% 2813
2016
Q3
$217K Buy
3,541
+1,886
+114% +$57K ﹤0.01% 1695
2016
Q2
$31.6K Buy
+1,655
New +$30.7K ﹤0.01% 2439
2016
Q1
Sell
-9,560
Closed -$369K 3030
2015
Q4
$369K Buy
9,560
+942
+11% +$30.5K ﹤0.01% 1541
2015
Q3
$277K Buy
8,618
+5,169
+150% +$175K ﹤0.01% 1736
2015
Q2
$105K Buy
3,449
+2,475
+254% +$50.6K ﹤0.01% 2057
2015
Q1
$12.9K Buy
+974
New +$13K ﹤0.01% 2606
2014
Q4
Sell
-2,345
Closed -$49.5K 3023
2014
Q3
$49.5K Buy
+2,345
New +$52.9K ﹤0.01% 2604
2014
Q1
Sell
-435
Closed -$8.86K 3775
2013
Q4
$8.86K Sell
435
-8,571
-95% -$255K ﹤0.01% 2719
2013
Q3
$425K Sell
9,006
-3,756
-29% -$145K ﹤0.01% 1654
2013
Q2
$485K Buy
+12,762
New +$456K ﹤0.01% 1585

Other funds holding SRPT